Jazz Pharmaceuticals plc (JAZZ) Stock

Jazz Pharmaceuticals plc (JAZZ) is a Healthcare stock trading at $224.57 (as of 2026-06-18), with a market capitalization of $14.84B and a trailing P/E of 2149.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Jazz Pharmaceuticals plc is a biopharmaceutical company that develops, manufactures, and commercializes prescription medicines and related product candidates for medical needs in the United States, Europe, and other international markets. Its portfolio focuses on neuroscience (including sleep medicine and movement disorders) and oncology (including hematologic and solid tumors).

Valuation — source: SEC EDGAR (first-party)
Price$224.57
Market Cap$14.84B
P/E Ratio2149.9
EV / EBITDA7261.0
Price / Book3.27
Price / Sales3.34
DCF Value (model)$451.30
DCF Upside vs Price101.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$4.27B
Net Margin-8.3%
Return on Equity0.7%
Debt / Equity1.18
Current Ratio2.04
Revenue Growth (YoY)4.9%
EPS Growth (YoY)-164.5%
FCF Growth (YoY)-4.5%
Financial Health — source: SEC EDGAR
Altman Z-Score1.67 (distress)
Valuation vs Sector & Industry
Stock P/E2149.9
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector10157.5%
vs Industry12355.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($1.06B)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORenee D. Gala
Employees2,800
CountryIE
IPO Date2007-06-01

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Ionis Pharmaceuticals, Inc. (IONS)
  • Moderna, Inc. (MRNA)
  • Exelixis, Inc. (EXEL)
  • BioMarin Pharmaceutical Inc. (BMRN)
  • Radiopharm Theranostics Limited (RADX)
  • Elanco Animal Health Incorporated (ELAN)
  • Qiagen N.V. (QGEN)
  • Axsome Therapeutics, Inc. (AXSM)
JAZZ earnings history · JAZZ institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.